SciELO - Scientific Electronic Library Online

 
vol.30 issue2Karyological study in the chilean rhatany Krameria cistoidea Hook. & Arn. (Krameriaceae)The Human Variome Project country node of Argentina in the first two years of activity: past, present and future author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

Share


BAG. Journal of basic and applied genetics

On-line version ISSN 1852-6233

Abstract

ROSERO, C.Y; MEJIA, L.G  and  CORREDOR, M. TP53 pathogenic variants related to cancer. BAG, J. basic appl. genet. [online]. 2019, vol.30, n.2, pp.27-40. ISSN 1852-6233.

TP53 or P53 is a tumor suppressor gene known as the "genome guardian", responsible for inducing cell response to DNA damage, by stopping the cell cycle in case of mutation, activating DNA repair enzymes, initiating senescence and activation of apoptosis. Mutations in the gene sequence can cause non-synonymous mutations or errors in the reading frame by insertion, deletion or displacement of nucleotides: e.g., c.358A>G mutation in exon 4 and variants located in exons 9 and 10 of the TD domain. Therefore, in this review, we will see that changes in the reading frame, including the loss of one or two base pairs could prevent accurate transcription or changes in the structure and function of the protein, and could completely impair reparation function. These changes promote self-sufficiency in growth signaling, insensitivity to anti-growth signals, and evasion of apoptosis, resulting in limitless replication and induction of metastatic angiogenesis, generating as a consequence the proliferation of tumor, neoplastic, and lymphoid cells. Taking into account the importance of TP53 in the regulation of the cell cycle, the objective of this review is to update information related to the role of this gene in the development of cancer and the description of genetic variations.

Keywords : Neoplasms; Nuclear phosphoprotein p53; Tumor Suppressor; Mutation; Clinvar; Uniprot.

        · abstract in Spanish     · text in English

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License